Publications

Below are the Vaccine Trials Groups publications.

Should you wish to search for publications authored by our researchers, please use PubMed Central (PMC) - the US National Institutes of Health (NIH) free digital archive of biomedical and life sciences journal literature.

>> Click here to connect to PubMed Central.

2009 Publications 

 

Strunk, T., Doherty, D., Richmond, P., Simmer, K., Charles, A., Levy, O., Liyanage, K., Smith, T., Currie, A., Burgner, D., Reduced levels of antimicrobial proteins and peptides in human cord blood plasma,  Arch Dis Child Fetal Neonatal  Ed  (2009)  94 3  F230-1    

 

Van der Most, R. G., Currie, A. J., Cleaver, A. L., Salmons, J., Nowak, A. K., Mahendran, S., Larma, I., Prosser, A., Robinson, B. W., Smyth, M. J., Scalzo, A. A., Degli-Esposti, M. A., Lake, R. A.,  Cyclophosphamide chemotherapy sensitizes tumor cells to TRAIL-dependent CD8 T cell-mediated immune attack resulting in suppression of tumor growth,  PLoS ONE  (2009)  4 9  e6982    

 

Van der Most, R. G., Currie, A. J., Mahendran, S., Prosser, A., Darabi, A., Robinson, B. W., Nowak, A. K., Lake, R. A.,  Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy,  Cancer Immunol Immunother  (2009)  58 8  1219-28    

 

Wiertsema, S. P, Leach A.J., Theories of otitis media pathogenesis, with a focus on Indigenous children. Med. J. Aust: 2009 Nov;191(9): S50-S54.  

 

A Prospective Case-Control Study to Evaluate the Effectiveness of Trivalent Inactivated Influenza Vaccine in Young Children (³ 6 months to < 5 years of age), The 6th World congress of the World Society for Paediatric Diseases Nov 2009 Buenos Aires – Argentina. Presenting Author: Robins C, Authors: Dixon G, Richmond P, Kelly H, Smith D, Keil A, Leeb A, Geelhoed G, Jacoby P, Williams S, Moore H, Carcione D, Van Buynder P, Bangor-Jones R.  

 

Naturally occurring and vaccine induced pneumococcal serotype specific serum IgG and IgA responses in otitis-prone children. oster presentation at the 7th International Symposium on Pneumococci and Pneumococcal Diseases, Tel Aviv, Israel, 2010, Wiertsema S. 

 

Predominance of non-typeable Haemophilus influenzae in the nasopharynx and middle ear of children with a history of recurrent acute otitis media. 27th Annual Meeting of the European Society for Paediatric Infectious Disease, Brussels, Belgium, 2009, Wiertsema, S. 

 

Pneumococcal surface protein A antibodies in children with and without recurrent Acute Otitis Media, 6th Extraordinary International Symposium on Recent Advances in Otitis Media, Seoul, Korea, 2009, Wiertsema, S. 

 

Currie, A, Immune adjuvant therapies for malignant mesothelioma: exacting a toll,  Lung Institute of Western Australia: 2009 Lung & Biological Science Symposium, Perth,  Australia, 2009

Currie A, Friend or Foe: Early Commensal Recognition by the Human Newborn,  Bi-annual Meeting of the Australian TLR research Network (TLROZ), Brisbane,  Australia, 2009.

Currie A, Impaired monocyte cytokine and lymphocyte responses to group B streptococcus in preterm infants,  Australasian Society for Immunology ASM, Brisbane,  Australia, 2009.  Fuery A, Assessment of Cellular Responses to a Combined Haemophilus influenzae Type B, Meningococcal C and Y Conjugate Vaccine.  Princess Margaret Hospital Research and Advances Symposium Oct 2009. 

 

Hobson M, Currie T, PAEDS Study: Paediatric Active Enhanced Disease surveillance Princess Margaret Hospital Research and Advances Seminar Oct 2009 Kirkham, L, A postdocs perspective (2009) Career seminar at University of Western Australia. 

 

Robins C, WAIVEing ‘Flu Goodbye in Young Children, Children’s Western Australian Influenza Vaccine Effectiveness Study WAIVE Princess Margaret Hospital Research and Advances Seminar Oct 2009 

 

Stoney T, Safety and Immunogenicity of a Prototype Adjuvanted Inactivated Split-Virus Influenza A (H5N1) Vaccine in Infants and Children, Princess Margaret Hospital Research and Advances Symposium Oct 2008. 

 

Wiertsema S, Bowman J, Kirkham LA, Murphy, Coates H, Richmond, Predominance of non-typeable Haemophilus influenzae in the nasopharynx and middle ear of children with a history of recurrent acute otitis media (2009). Research Advances Seminar. PMH, Perth, Australia. 

 

Wiertsema, S, Development of anti-PspA antibody levels in children with and without recurrent acute otitis media, 27th Annual Meeting of the European Society for Paediatric Infectious Disease, Brussels, Belgium, 2009. 

 

Wiertsema S, Kirkham L and Thornton R, Immunology and Microbiology of Otitis Media, June, 2009, Infectious Diseases Research Group;TICHR, Perth, Australia. Wiertsema, S, Predominance of non-typeable Haemophilus influenzae in the nasopharynx and middle ear of children with a history of recurrent acute otitis media. 6th Extraordinary International Symposium on Recent Advances in Otitis Media, Seoul, Korea, 2009.   

 

 

Coates H, Thornton R, Langlands J, Filion P, Keil AD, Vijayasekaran S, Richmond P. , The role of chronic infection in children with otitis media with effusion: Evidence for intracellular persistence of bacteria. Otolaryngol Head Neck Surg. 2008 Jun;138(6):778-81. 

 

Currie, A. J, van der Most, R. G., Broomfield, S. A., Prosser, A. C., Tovey, M. G., Robinson, B. W.,  Targeting the effector site with IFN-alphabeta-inducing TLR ligands reactivates tumor-resident CD8 T cell responses to eradicate established solid tumors,  J Immunol  (2008)  180 3  1535-44    

 

Pym M, Adams J, Booy R, Buttery J, Elia S, Elliott E Gold M, Heath C, Marshall H, McIntyre P,  Phillips A,  Rhind L, Richmond P, Royle J, Wall K, Wood N and Zurynski Y. Paediatric Active Enhanced Disease Surveillance (PAEDS): Twelve month trial of a new surveillance mechanism for Australia  ??? where published  

 

Skinner, RS, Garland SM, Stanley, MA, Pitts M, Quinn, M. Human Papillomavirus vaccination for the prevention of cervical neoplasia: is it appropriate to vaccinate women older than 26? MJA 2008 Feb: 188 (4):238-42  

 

2008 Poster Presentations 

A Randomised, placebo-controlled, Vaccine Michael D Nissen1, Helen Marshall2, Peter Richmond3, Stephen Lambert1, Don Roberton2, William Gruber4, Tom Jones4,Stephen Lockhart5, Ashoni Arora4  

 

Australian Society for Immunology Meeting, Dec 2008, Canberra, ACT: Assessment of Cellular Responses to Tetanus Toxoid Carrier Protein.  Fuery A

 

Combined Biological Sciences Meeting, Aug 2008, Perth, WA: Assessment of Cellular Responses to Tetanus Toxoid Carrier Protein for Analyses of Meningococcalconjugate vaccines. Fuery A 

 

Consumers in Research Conference, Perth WA, March 2008: We’re Helping Save Kids from Meningitis. Adams JL, Hutton H, Rhind L, Kent J, McDonald F, Stoney T, Phillips A, Richmond P 

 

Perth Immunology Group Meeting, Oct 2008, Perth, WA:  Assessment of Cellular Responses to Tetanus Toxoid Carrier Protein for Analyses of Meningococcal conjugate vaccines. Fuery A

 

PHAA 11th National Immunisation Conference, Gold Coast Qld, Sep 2008: Multiplex system for measuring vaccine specific IgG antibody responses. Curtis S, Borrow R, Laher G, Frankland S, Richmond P.

 

 

2006 Publications

 

 

Jacquet JM, Bégué P, Grimprel E, Richmond P et al. Safety and immunogenicity of a combined DTPa-IPV vaccine administered as a booster from 4 years of age: a review Vaccine 2006; 24:2440-8.

 

Goldblatt D, Southern J, Ashton L, Richmond P, et al. Immunogenicity and boosting following a reduced number of doses of a Pneumococcal Conjugate Vaccine in infants and toddlers. Pediatric Infectious Disease J 2006 25(4):312-9.

 

Taylor R, Richmond P, Upham J. Toll-like receptor 2 ligands inhibit Th2 responses to mite allergen J Allergy Clinical Immunology 2006;117:1148-54

 

Marshall H, H. Nolan T, Roberton D, Richmond P et al A comparison of booster immunisation with a combination DTPa-IPV vaccine or DTPa plus IPV in separate injections when co-administered with MMR, at age 4 – 6 years. Vaccine 2006; 24(35-36):6120-8.

 

Galati JC, Harsley S, Richmond P., Carlin JB. The burden of rotavirus-related illness among young children on the Australian health care system. ANZ J Public Health 2006; 30:416-21

 

Moore H, Burgner D, Carville KS, Jacoby P, Richmond P, Lehmann D. Diverging trends for lower respiratory infections in non-Aboriginal and Aboriginal children J Paediatrics and Child Health (in press, accepted October 2006)

 

Carville KS, Lehmann D, Hall G, Moore H, Richmond P, deKlerk N, Burgner D. Infection is the major component of the disease burden in Aboriginal and non-Aboriginal Australian children: a population-based study. Pediatric Infectious Disease J (In press, accepted Oct 2006)

 

Yerkovich ST, Rowe J, Richmond P, Suriyaarachchi D, Heaton T, Hollams E, Ladyman C, Serralha M, Sadowska A, Loh R, Wesselingh SL, Sly PD Holt PG. Assessment of the potency and potential immunomodulatory effects of the Measles Mumps Rubella-Varicella vaccine in infants. Vaccine 2007; 25:1764-70.

 

Noakes P, Taylor A, Hale J, Breckler L, Richmond P, Devadason SG, Prescott SL. The effects of maternal smoking on early mucosal immunity and sensitization at 12 months of age. Pediatr Allergy Immunol. 2007;18:118-27

 

Nolan T, Lambert S, Roberton D, Marshall H, Richmond P, Streeton C. A DTPa-HBV-IPV vaccine for primary vaccination of infants. J Paediatrics and Child Health (in press, accepted December 2006)

 

Block SL, Nolan T, Sattler C, Protocol 016 Study Group et al. Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papilloma Virus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women. Pediatrics. 2006; 118:2135-45.